ALPHA COGNITION INC.

Profile

Company Names

ALPHA COGNITION INC.
NEURODYN COGNITION INC.

Addresses

1200 - 750 WEST PENDER STREET, VANCOUVER, A1 V6C 2T8

20073 FIDDLER-S GREEN, FRISCO, TX 75036

301 - 1228 HAMILTON STREET, VANCOUVER, A1 V6B 6L2

439 HELMCKEN STREET, VANCOUVER, A1 V6B 2E6

Phone Numbers

(858) 344-4375
(604) 564-9244
(604) 684-3323

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$27,879,211.00

Number of Funding Rounds:

17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2024-10-21 
$0.00 
$346,944.00 
$346,944.00 
 
16
2024-09-24 
$4,545,000.00 
$11,143,857.00 
$6,598,857.00 
Equity, Debt 
15
2024-01-24 
$2,839,628.00 
$6,840,921.00 
$4,001,293.00 
Equity 
14
2023-12-22 
$1,762,097.00 
$4,245,053.00 
$2,482,956.00 
Equity 
13
2023-11-08 
$1,009,999.00 
$1,721,588.00 
$711,589.00 
Equity 
12
2023-10-16 
$343,999.00 
$586,361.00 
$242,362.00 
Equity 
11
2023-08-31 
$1,260,837.00 
$2,149,152.00 
$888,315.00 
Equity 
10
2023-03-15 
$1,286,748.00 
$3,254,716.00 
$1,967,968.00 
Equity 
9
2023-02-16 
$1,847,827.00 
$4,673,916.00 
$2,826,089.00 
Equity 
8
2021-10-01 
$424,983.00 
$920,796.00 
$495,813.00 
Equity 
7
2020-12-18 
$1,457,000.00 
$1,457,000.00 
$0.00 
 
6
2020-04-27 
$1,915,000.00 
$1,915,000.00 
$0.00 
Debt 
5
2019-08-30 
$5,951,093.00 
$5,951,093.00 
$0.00 
Equity 
4
2018-07-05 
$2,000,000.00 
$4,000,000.00 
$2,000,000.00 
Debt 
3
2017-02-28 
$200,000.00 
$200,000.00 
$0.00 
Equity 
2
2016-04-04 
$385,000.00 
$385,000.00 
$0.00 
Equity 
1
2015-09-30 
$650,000.00 
$650,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAJEEV 
 
BAKSHI 
DIRECTOR
RAJEEV 
ROB 
BAKSHI 
DIRECTOR
ROB 
 
BAKSHI 
DIRECTOR
KENNETH 
 
CAWKELL 
DIRECTOR, EXECUTIVE OFFICER
KENNETH 
A. 
CAWKELL 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
L. 
CERVELLI 
DIRECTOR
LAUREN 
 
D-ANGELO 
EXECUTIVE OFFICER
HENRY 
 
DU 
EXECUTIVE OFFICER
JOHN 
 
HAVENS 
DIRECTOR
DON 
 
KALKOFEN 
EXECUTIVE OFFICER
DENIS 
 
KAY 
EXECUTIVE OFFICER
DENIS 
G. 
KAY 
EXECUTIVE OFFICER, DIRECTOR
ALFRED 
 
MAELICKE 
DIRECTOR
MICHAEL 
 
MCFADDEN 
EXECUTIVE OFFICER, DIRECTOR
JEREMY 
 
MERTZ 
DIRECTOR
MADOLYN 
 
MERTZ 
DIRECTOR
PHILLIP 
 
MERTZ 
DIRECTOR
PHILLIP 
P. 
MERTZ 
DIRECTOR
FREDERICK 
 
SANCILIO 
DIRECTOR, EXECUTIVE OFFICER
JEREMY 
 
WRIGHT 
EXECUTIVE OFFICER
JAY 
 
YOO 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2024-10-21 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity, Debt 
2024-09-24 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2024-01-24 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-12-22 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-11-08 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-10-16 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-08-31 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-03-15 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2023-02-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-12-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-04-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-05 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
THE BENCHMARK COMPANY, LLC
NONE
NONE
SPARTAN CAPITAL HOLDINGS, LLC
NONE
NONE
SPARTAN CAPITAL SECURITIES, LLC
NONE
NONE
SPARTAN CAPITAL SECURITIES, LLC